Formula: | C19H23ClF3NO3 |
Molecular Weight: | 405.84 |
Rotatable Bond Donors: | 4 |
clogP: | 5.49 |
Topological Polar Surface Area: | 49.77 |
Lipinski's RO5: | MW: 405.84 HBA: 4 HBD: 1 RB: 4 LogP: 5.49 |
Rule of Three: | MW: 405.84 HBA: 4 HBD: 1 RB: 4 LogP: 5.49 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC209053267 | 1.0 | ZINC209053267 RDKit 3D 27 29 0 0 0 0 0 0 0 0999 V2000 -7.0928 -1.8944 -1.6578 O 0 0 0 0 0 0 0 0 0 0 0 0 -7.0710 -0.8816 -0.9758 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.7277 0.2636 -1.2788 O 0 0 0 0 0 0 0 0 0 0 0 0 -6.3246 -0.7293 0.3130 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.8798 -0.4021 0.0158 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.5300 0.9579 0.5838 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2396 0.9715 1.3781 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1010 0.1966 0.7322 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5329 -1.1808 0.2476 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9837 -1.4995 0.5428 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0105 -0.0050 1.7775 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0394 1.1588 1.8130 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6385 1.3111 0.5268 N 0 0 0 0 0 0 0 0 0 0 0 0 2.0156 1.0281 0.5493 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5966 0.3298 -0.5280 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9546 0.0119 -0.5915 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3500 -0.6872 -1.6971 O 0 0 0 0 0 0 0 0 0 0 0 0 5.7215 -1.0578 -1.7389 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9508 -1.7455 -2.8803 F 0 0 0 0 0 0 0 0 0 0 0 0 6.5190 0.0321 -1.7401 F 0 0 0 0 0 0 0 0 0 0 0 0 6.0419 -1.8506 -0.6950 F 0 0 0 0 0 0 0 0 0 0 0 0 4.7878 0.4126 0.4423 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2674 1.1351 1.5094 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9048 1.4491 1.5632 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4398 2.4513 2.8946 Cl 0 0 0 0 0 0 0 0 0 0 0 0 -0.0807 0.8172 -0.6460 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5746 0.9895 -0.4601 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 2 3 1 0 2 4 1 0 4 5 1 0 5 6 1 0 6 7 1 0 7 8 1 0 8 9 1 0 9 10 1 0 8 11 1 0 11 12 1 0 12 13 1 0 13 14 1 0 14 15 2 0 15 16 1 0 16 17 1 0 17 18 1 0 18 19 1 0 18 20 1 0 18 21 1 0 16 22 2 0 22 23 1 0 23 24 2 0 24 25 1 0 13 26 1 0 26 27 1 0 10 5 1 0 24 14 1 0 27 8 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |